Regeneron’s revenue in Q2 exceeds forecasts
Regeneron Pharmaceuticals reported on Thursday the company’s revenue in the second quarter of 2021 surged 163% to $5.14 billion, significantly outperforming the figure estimated by analysts.
Mea…
- Suga: Not considering nationwide emergency state
- EU: Members to make own decisions on jab’s 3rd dose
